OTHER GROUP COMPANIES
market

Zydus Lifesciences consolidated net profit declines 41.47% in the March 2022 quarter

Sales rise 4.49% to Rs 3741.80 crore

May 20, 2022 2:44 IST | capital market
Net profit of Zydus Lifesciences declined 41.47% to Rs 397.40 crore in the quarter ended March 2022 as against Rs 679.00 crore during the previous quarter ended March 2021. Sales rose 4.49% to Rs 3741.80 crore in the quarter ended March 2022 as against Rs 3580.90 crore during the previous quarter ended March 2021. For the full year,net profit rose 110.32% to Rs 4487.30 crore in the year ended March 2022 as against Rs 2133.60 crore during the previous year ended March 2021. Sales rose 4.97% to Rs 14827.60 crore in the year ended March 2022 as against Rs 14125.00 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear Ended
?Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales3741.803580.90 4 14827.6014125.00 5
OPM %18.7823.11 -22.5323.50 -
PBDT743.30774.00 -4 5684.103205.90 77
PBT557.90598.70 -7 4971.102536.30 96
NP397.40679.00 -41 4487.302133.60 110
Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity